Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Sugrue, DM"'
Autor:
Hill, NR, Groves, L, Dickerson, C, Boyce, R, Lawton, S, Hurst, M, Pollock, KG, Sugrue, DM, Lister, S, Arden, C, Davies, DW, Martin, A-C, Sandler, B, Gordon, J, Farooqui, U, Clifton, D, Mallen, C, Rogers, J, Camm, AJ, Cohen, AT
Objective:The PULsE-AI trial sought to determine the effectiveness of a screening strategy that included a machine learning risk prediction algorithm in conjunction with diagnostic testing for identification of undiagnosed atrial fibrillation (AF) in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::669a219acd708384b8b9e79e7bf73096
Autor:
Pollock KG; Bristol Myers Squibb Pharmaceutical Ltd, Uxbridge, UK., Dickerson C; Health Economics and Outcomes Research Ltd, Cardiff, UK., Kainth M; Primrose Lane Health Centre, Wolverhampton, UK., Lawton S; School of Medicine, Keele University, Staffordshire, UK., Hurst M; Bristol Myers Squibb Pharmaceutical Ltd, Uxbridge, UK., Sugrue DM; Health Economics and Outcomes Research Ltd, Cardiff, UK., Arden C; University Hospital Southampton, Southampton, UK., Davies DW; London Heart Practice, London, UK., Martin AC; Service de Cardiologie, Université de Paris, Innovative Therapies in Haemostasis, INSERM, Hôpital Européen Georges Pompidou, 20 rue Leblanc, Paris, France., Sandler B; Bristol Myers Squibb Pharmaceutical Ltd, Uxbridge, UK., Gordon J; Health Economics and Outcomes Research Ltd, Cardiff, UK. jason.gordon@heor.co.uk., Farooqui U; Bristol Myers Squibb Pharmaceutical Ltd, Uxbridge, UK., Clifton D; Institute of Biomedical Engineering, Department of Engineering Science, University of Oxford, Oxford, UK., Mallen C; School of Medicine, Keele University, Staffordshire, UK., Rogers J; PHASTAR, London, UK., Hill NR; Bristol Myers Squibb Pharmaceutical Ltd, Uxbridge, UK., Camm AJ; Cardiology Clinical Academic Group, Molecular & Clinical Sciences Research Institute, St. George's University of London, London, UK., Cohen AT; Department of Haematological Medicine, Guys and St Thomas' NHS Foundation Trust, King's College London, London, UK.
Publikováno v:
BMC primary care [BMC Prim Care] 2024 Jan 02; Vol. 25 (1), pp. 7. Date of Electronic Publication: 2024 Jan 02.
Autor:
Hill NR; Bristol Myers Squibb Pharmaceutical Ltd, Uxbridge, UK., Groves L; Health Economics and Outcomes Research Ltd, Cardiff, UK., Dickerson C; Health Economics and Outcomes Research Ltd, Cardiff, UK., Ochs A; Health Economics and Outcomes Research Ltd, Cardiff, UK., Pang D; Health Economics and Outcomes Research Ltd, Cardiff, UK., Lawton S; School of Medicine, Keele University, Staffordshire, UK., Hurst M; Health Economics and Outcomes Research Ltd, Cardiff, UK., Pollock KG; Bristol Myers Squibb Pharmaceutical Ltd, Uxbridge, UK., Sugrue DM; Health Economics and Outcomes Research Ltd, Cardiff, UK., Tsang C; Health Economics and Outcomes Research Ltd, Cardiff, UK., Arden C; University Hospital Southampton, Southampton, UK., Wyn Davies D; St Mary's Hospital, London, UK., Martin AC; Université de Paris, INSERM, Innovative Therapies in Haemostasis, F-75006 Paris, France.; Service de Cardiologie, AP-HP, Hôpital Européen Georges Pompidou, F-75015 Paris, France., Sandler B; Bristol Myers Squibb Pharmaceutical Ltd, Uxbridge, UK., Gordon J; Health Economics and Outcomes Research Ltd, Cardiff, UK., Farooqui U; Bristol Myers Squibb Pharmaceutical Ltd, Uxbridge, UK., Clifton D; Institute of Biomedical Engineering, Department of Engineering Science, University of Oxford, Oxford, UK., Mallen C; School of Medicine, Keele University, Staffordshire, UK., Rogers J; PHASTAR, London, UK., Camm AJ; Cardiology Clinical Academic Group, Molecular & Clinical Sciences Research Institute, St George's University of London, London, UK., Cohen AT; Department of Haematological Medicine, Guys and St Thomas' NHS Foundation Trust, King's College London, London, UK.
Publikováno v:
European heart journal. Digital health [Eur Heart J Digit Health] 2022 Mar 23; Vol. 3 (2), pp. 195-204. Date of Electronic Publication: 2022 Mar 23 (Print Publication: 2022).
Autor:
Hill NR; Bristol Myers Squibb Pharmaceuticals Ltd., Uxbridge, UK., Groves L; HEOR, Unit A, Health Economics and Outcomes Research Ltd., Cardiff, UK., Dickerson C; HEOR, Unit A, Health Economics and Outcomes Research Ltd., Cardiff, UK., Boyce R; HEOR, Unit A, Health Economics and Outcomes Research Ltd., Cardiff, UK., Lawton S; School of Medicine, Keele University, Staffordshire, UK., Hurst M; Bristol Myers Squibb Pharmaceuticals Ltd., Uxbridge, UK., Pollock KG; Bristol Myers Squibb Pharmaceuticals Ltd., Uxbridge, UK., Sugrue DM; HEOR, Unit A, Health Economics and Outcomes Research Ltd., Cardiff, UK., Lister S; Bristol Myers Squibb Pharmaceuticals Ltd., Uxbridge, UK., Arden C; NHS Foundation Trust, University Hospital Southampton, Southampton, UK., Davies DW; London Heart Practice, London, UK., Martin AC; Université de Paris, Innovative Therapies in Haemostasis, INSERM, Hôpital Européen Georges Pompidou, Service de Cardiologie, Paris, France., Sandler B; Bristol Myers Squibb Pharmaceuticals Ltd., Uxbridge, UK., Gordon J; HEOR, Unit A, Health Economics and Outcomes Research Ltd., Cardiff, UK., Farooqui U; Bristol Myers Squibb Pharmaceuticals Ltd., Uxbridge, UK., Clifton D; Institute of Biomedical Engineering, Department of Engineering Science, University of Oxford, Oxford, UK., Mallen C; School of Medicine, Keele University, Staffordshire, UK., Rogers J; Statistical Research and Consultancy, Unit 2, PHASTAR, London, UK., Camm AJ; Cardiology Clinical Academic Group, Molecular & Clinical Sciences Research Institute, St. George's University of London, London, UK., Cohen AT; Department of Haematological Medicine, Guys and St Thomas' NHS Foundation Trust, King's College London, London, UK.
Publikováno v:
Journal of medical economics [J Med Econ] 2022 Jan-Dec; Vol. 25 (1), pp. 974-983.
Autor:
Asker B; GIT Center, Baghdad, Iraq., Jawad R; GIT Center, Baghdad, Iraq., Asreah R; Baghdad Teaching Hospital, Baghdad, Iraq., Jamal H; Sulaimania Hospital, Sulaimania, Iraq., Jassem A; Najaf Hospital, Najaf, Iraq., Inaya MA; Najaf Hospital, Najaf, Iraq., Baker HA; Sulaimania Hospital, Sulaimania, Iraq., Kozma S; Gilead Sciences, Dubai, United Arab Emirates., Mansour E; Gilead Sciences, Dubai, United Arab Emirates., McNamara B; Health Economics and Outcomes Research Ltd, Cardiff, UK., Miller R; Health Economics and Outcomes Research Ltd, Cardiff, UK., Darlington O; Health Economics and Outcomes Research Ltd, Cardiff, UK., McEwan P; Health Economics and Outcomes Research Ltd, Cardiff, UK., Sugrue DM; Health Economics and Outcomes Research Ltd, Cardiff, UK. daniel.sugrue@heor.co.uk., Jarallah H; Basra Hospital, Basra, Iraq.
Publikováno v:
PharmacoEconomics [Pharmacoeconomics] 2021 Nov; Vol. 39 (11), pp. 1327-1341. Date of Electronic Publication: 2021 Aug 16.
Autor:
Hill NR; Bristol Myers Squibb Pharmaceutical Ltd, Uxbridge, UK. Electronic address: Nathan.Hill@bms.com., Arden C; Park Surgery, Chandlers Ford, Hampshire, UK. Electronic address: chrisarden@nhs.net., Beresford-Hulme L; Health Economics and Outcomes Research Ltd, Cardiff, UK. Electronic address: l.m.beresford91@googlemail.com., Camm AJ; Cardiology Clinical Academic Group, Molecular & Clinical Sciences Research Institute, St. George's University of London, London, UK. Electronic address: jcamm@sgul.ac.uk., Clifton D; Institute of Biomedical Engineering, Department of Engineering Science, University of Oxford, UK. Electronic address: davidc@robots.ox.ac.uk., Davies DW; St Mary's Hospital, London, UK., Farooqui U; Bristol Myers Squibb Pharmaceutical Ltd, Uxbridge, UK. Electronic address: Usman.Farooqui@bms.com., Gordon J; Health Economics and Outcomes Research Ltd, Cardiff, UK. Electronic address: jason.gordon@heor.co.uk., Groves L; Health Economics and Outcomes Research Ltd, Cardiff, UK. Electronic address: lara.groves@heor.co.uk., Hurst M; Health Economics and Outcomes Research Ltd, Cardiff, UK. Electronic address: michael.hurst@heor.co.uk., Lawton S; School of Medicine, Keele University, Staffordshire, UK. Electronic address: s.a.lawton@keele.ac.uk., Lister S; Bristol Myers Squibb Pharmaceutical Ltd, Uxbridge, UK. Electronic address: Steven.Lister@bms.com., Mallen C; School of Medicine, Keele University, Staffordshire, UK. Electronic address: c.d.mallen@keele.ac.uk., Martin AC; Université de Paris, Innovative Therapies in Haemostasis, INSERM, Hôpital Européen Georges Pompidou, Service de Cardiologie, 20 rue Leblanc, Paris, France., McEwan P; Health Economics and Outcomes Research Ltd, Cardiff, UK. Electronic address: phil.mcewan@heor.co.uk., Pollock KG; Bristol Myers Squibb Pharmaceutical Ltd, Uxbridge, UK. Electronic address: Kevin.Pollock@bms.com., Rogers J; PHASTAR, London, UK. Electronic address: jennifer.rogers@phastar.com., Sandler B; Bristol Myers Squibb Pharmaceutical Ltd, Uxbridge, UK. Electronic address: Belinda.Sandler@bms.com., Sugrue DM; Health Economics and Outcomes Research Ltd, Cardiff, UK. Electronic address: daniel.sugrue@heor.co.uk., Cohen AT; Department of Haematological Medicine, Guys and St Thomas' NHS Foundation Trust, King's College London, London, UK. Electronic address: alexander.cohen@kcl.ac.uk.
Publikováno v:
Contemporary clinical trials [Contemp Clin Trials] 2020 Dec; Vol. 99, pp. 106191. Date of Electronic Publication: 2020 Oct 19.
Autor:
Sugrue DM; Health Economics and Outcomes Research Limited, Rhymney House, Unit A Copse Walk, Cardiff Gate Business Park, Cardiff, CF23 8RB, UK. daniel.sugrue@heor.co.uk., Ward T; Health Economics and Outcomes Research Limited, Rhymney House, Unit A Copse Walk, Cardiff Gate Business Park, Cardiff, CF23 8RB, UK., Rai S; Health Economics and Outcomes Research Limited, Rhymney House, Unit A Copse Walk, Cardiff Gate Business Park, Cardiff, CF23 8RB, UK., McEwan P; Health Economics and Outcomes Research Limited, Rhymney House, Unit A Copse Walk, Cardiff Gate Business Park, Cardiff, CF23 8RB, UK., van Haalen HGM; AstraZeneca, Gothenburg, Sweden.
Publikováno v:
PharmacoEconomics [Pharmacoeconomics] 2019 Dec; Vol. 37 (12), pp. 1451-1468.
Autor:
Hill NR; Bristol-Myers Squibb Pharmaceutical Ltd, Uxbridge, United Kingdom., Ayoubkhani D; Health Economics and Outcomes Research Ltd, Cardiff, United Kingdom., McEwan P; Health Economics and Outcomes Research Ltd, Cardiff, United Kingdom., Sugrue DM; Health Economics and Outcomes Research Ltd, Cardiff, United Kingdom., Farooqui U; Bristol-Myers Squibb Pharmaceutical Ltd, Uxbridge, United Kingdom., Lister S; Bristol-Myers Squibb Pharmaceutical Ltd, Uxbridge, United Kingdom., Lumley M; Pfizer Ltd, Surrey, United Kingdom., Bakhai A; Department of Cardiology, Royal Free Hospital, London, United Kingdom., Cohen AT; Department of Haematological Medicine, Guys and St Thomas' NHS Foundation Trust, King's College London, London, United Kingdom., O'Neill M; Division of Cardiovascular Medicine, Guys and St Thomas' NHS Foundation Trust, King's College London, London, United Kingdom., Clifton D; Department of Engineering Science, University of Oxford, Oxford, United Kingdom., Gordon J; Health Economics and Outcomes Research Ltd, Cardiff, United Kingdom.
Publikováno v:
PloS one [PLoS One] 2019 Nov 01; Vol. 14 (11), pp. e0224582. Date of Electronic Publication: 2019 Nov 01 (Print Publication: 2019).
Autor:
Gordon JP; aHealth Economics and Outcomes Research Ltd, Monmouth bSwansea Centre for Health Economics, Swansea University, Wales cOxon Epidemiology dTakeda Pharmaceuticals, Takeda Development Centre, London, UK eUniversity of Adelaide, Department of Public Health, Adelaide, Australia., McEwan PC, Maguire A, Sugrue DM, Puelles J
Publikováno v:
European journal of gastroenterology & hepatology [Eur J Gastroenterol Hepatol] 2015 Jul; Vol. 27 (7), pp. 804-12.
Autor:
Prod'homme V; Department of Infection, Immunity and Biochemistry, Section of Medical Microbiology, School of Medicine, Cardiff University, Cardiff, UK., Sugrue DM; Department of Infection, Immunity and Biochemistry, Section of Medical Microbiology, School of Medicine, Cardiff University, Cardiff, UK., Stanton RJ; Department of Infection, Immunity and Biochemistry, Section of Medical Microbiology, School of Medicine, Cardiff University, Cardiff, UK., Nomoto A; Department of Microbiology, Graduate School of Medicine, University of Tokyo, Japan., Davies J; Department of Infection, Immunity and Biochemistry, Section of Medical Microbiology, School of Medicine, Cardiff University, Cardiff, UK., Rickards CR; Department of Infection, Immunity and Biochemistry, Section of Medical Microbiology, School of Medicine, Cardiff University, Cardiff, UK., Cochrane D; Department of Infection, Immunity and Biochemistry, Section of Medical Microbiology, School of Medicine, Cardiff University, Cardiff, UK., Moore M; Department of Infection, Immunity and Biochemistry, Section of Medical Microbiology, School of Medicine, Cardiff University, Cardiff, UK., Wilkinson GWG; Department of Infection, Immunity and Biochemistry, Section of Medical Microbiology, School of Medicine, Cardiff University, Cardiff, UK., Tomasec P; Department of Infection, Immunity and Biochemistry, Section of Medical Microbiology, School of Medicine, Cardiff University, Cardiff, UK.
Publikováno v:
The Journal of general virology [J Gen Virol] 2010 Aug; Vol. 91 (Pt 8), pp. 2034-2039. Date of Electronic Publication: 2010 Apr 21.